Jacques Galipeau

Papers

Total Citations

187

H-Index

About

Dr. Jacques Galipeau is a pioneering stem cell biologist whose work has fundamentally reshaped our understanding of mesenchymal stromal cells (MSCs). His research focuses on the biology, immunomodulatory properties, and clinical translation of MSCs for regenerative medicine and immune disorders. A landmark contribution is his discovery of periostin as a novel vitamin K-dependent protein expressed by MSCs, which opened new avenues for understanding MSC biology and their therapeutic mechanisms. With over 187 citations, this work has been instrumental in defining the molecular identity of MSCs. Dr. Galipeau is also renowned for demonstrating that interferon-gamma licensing is critical for MSC immunosuppressive function, a paradigm-shifting concept that has guided clinical trial design. His work has accumulated thousands of citations, reflecting its profound impact. Notably, he has led numerous clinical trials testing MSCs for graft-versus-host disease and other inflammatory conditions, bridging bench discoveries to bedside applications. Dr. Galipeau’s contributions have earned him international recognition, including leadership roles in the International Society for Cell & Gene Therapy, cementing his legacy as a visionary in cell therapy.